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Summary 
T lymphocytes play a primary role in recovery from viral infections and in antiviral immunity. 
Although viral-specific CD8 + and CD4 + T  ceils have been shown to be able to lyse vitally 
infected targets in vitro and promote recovery from lethal infection in vivo, the role of CD4 + 
T  lymphocytes and their mechanism(s) of action in viral immunity are not well understood. 
The ability to further dissect the role that CD4 + T  cells play in the immune response to a 
number of pathogens has been greatly enhanced by evidence for more extensive heterogeneity 
among the CD4 + T lymphocytes. To further examine the role of CD4 + T cells in the immune 
response to influenza infection, we have generated influenza virus-specific CD4 + T cell clones 
from influenza-primed BALB/c mice with differential cytokine secretion profiles that are defined 
as T helper type I (Thl) clones by the production of interleukin 2 (IL-2) and interferon 3' (IFN- 
3'), or as Th2 dunes by the production of IL-4, IL-5, and IL-10. Our studies have revealed that 
Thl clones are cytolytic in vitro and protective against lethal challenge with virus in vivo, whereas 
Th2 clones are noncytolytic and not protective. Upon further evaluation of these donal populations 
we have shown that not only are the Th2 clones nonprotective, but that pulmonary pathology 
is exacerbated as compared with control mice as evidenced by delayed viral clearance and massive 
pulmonary eosinophilia. These data suggest that virus-specific CD4 + T cells of the Th2 subset 
may not play a primary role in virus clearance and recovery and may lead to immune mediated 
potentiation of injury. 
B 
oth antigen-nonspecific effector mechanisms, e.g., nat- 
ural killer cells, (1, 2) and antigen-specific effector mech- 
anisms,  e.g., T  lymphocytes (3), play a crucial  role in the 
host response to virus infection. Many studies over the past 
20 yr have added to the understanding of the function and 
heterogeneity of T lymphocytes responding during virus in- 
fection. Early studies suggested that the CD4-8 + CTL is 
the crucial antigen-specific  effector cell in the host immune 
response to viral infection (4). In the influenza modal, the 
role that CD8 + CTLs play in the host immune response to 
this virus has been extensively examined (5-10). In early studies 
it was shown that CD8 § CTLs, which are restricted by class 
I MHC molecules, can lyse vitally infected cells and promote 
recovery from viral infection in vivo. In addition, IFN-3, and 
other cytokines with antiviral activity, e.g., TNF-/5, have been 
suggested to play a role in viral clearance mediated by CD8 + 
CTLs (10, 11). 
A number of laboratories have examined the role of the 
CD4+8 -  T cell in host immune response to virus infection 
in general (3) and influenza infection in particular (12-16). 
Results from this laboratory demonstrated that influenza- 
specific  CD4 +  T  lymphocytes  can  lyse  vitally  infected 
targets in vitro and eliminate infectious virus and promote 
recovery from lethal experimental infection when clones of 
these CD4 + T cells are adoptively transferred in vivo (12). 
Studies involving transgenic mice homozygous for the/32- 
microglobulin (/3z-m) gene disruption that lack functional 
class I  MHC  and CD8 + T  cells, have demonstrated that 
influenza A virus can be cleared from the respiratory tract 
of these mice, thus suggesting the role of CD4 + T cells and 
natural killer cells as in vivo antiviral effectors (14). Addi- 
tionally, work using athymic (nude) mice has added further 
evidence that influenza-specific class II-restricted T cells can 
promote B cell responses in vivo, and that antihemagglutinin 
(HA) 1 antibodies alone can mediate clearance of influenza 
virus  (16). 
The ability to further dissect the role that CD4 + T cells 
1 Abbreviations used in this paper: HA, hemagglutinin; HAU, HA units; 
HII~_,S, heat-inactivated I~,S; HPF, high powered fields; huK, human 
lecombinant; KSV, respiratory syncytial virus. 
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been greatly enhanced by evidence for more extensive heter- 
ogeneity among the CD4 + T lymphocytes (17). Stable long- 
term CD4 + clones that secrete IL-2 and IFN-3, upon anti- 
genic stimulation are classified as belonging to the Thl subset, 
whereas those secreting IL-4, IL-5, aM IL-10 belong to the 
Th2 subset. The functions of Thl aM Th2 donal popula- 
tions are markedly different. Although both Thl and Th2 
cells can provide help for B cell (antibody) responses, Th2 
cells are more effective (18). Thl clones preferentially induce 
ddayed-type hypersensitivity and macrophage activation (19). 
For each of these functions, the profile of the cytokines secreted 
by Thl and Th2 cells are the primary predictors of the differ- 
ences in effector functions of these CD4 + T cell subsets  in 
vivo. 
A number of infectious disease models have examined the 
differential functional role of Thl vs. Th2 T ceils. In the well 
described Leishmania model, Thl and Th2 ceils, aM/or their 
respective cytokines, have different effects on the clearance 
of the microorganism during experimental infection (20-23). 
Recent studies on experimentally induced murine acquired 
immunoddidency syndrome (MAIDS) have suggested that 
Th2 cytokines play a central role in the progression of that 
disease (24). In addition, work by Clerici et al. (25) has sug- 
gested that production of Th2 cytokines by HIV positive in- 
dividuals may be a sensitive marker for progression to AIDS. 
However, at present there is very little information on the 
in vivo antiviral effector activity of CD4 + T cells of the Th2 
subset (26). 
In the present study we have examined a panel of influenza- 
specific CD4 + clones with cytokine secretion profiles that 
define them as belonging to either the Thl or Th2 subset. 
We have found that clonal populations of influenza-specific 
Thl T cells are cytolytic in vitro and protective in vivo, and 
that Th2 clones are noncytolytic in vitro and do not pro- 
mote recovery in vivo. In addition, adoptive transfer of Th2 
clones lead to massive pulmonary eosinophilia in the reapients 
and delayed viral clearance as evidenced by elevated viral titers 
as compared with control infected animals. These data dem- 
onstrate in a model of acute progressive viral infection that 
CD4 + Th2 cells do not play a primary role in virus dear- 
ance in vivo, and that the induction of this in vivo effector 
activity may be detrimental to the host recovery process. 
Materials and Methods 
Animals.  Murine pathogen-free male and female BALB/c (H- 
2a), C57B1/6 (H-2b), and C3H (H-2  k) mice 4-6 wk of age were 
purchased from Taconic Farms, Inc., Germantown, NY and used 
at 6-9 wk of age. 
V/roses.  Influenza virus strains A/JAP/57 (A/JAPAN/305/57 
[H2N2]),  A/JAP/62  (A/JAPAN/170/62  [H2N2]),  A/AA/67 
(A/Ann Arbor/7/67 [H2N2]), A/TAI/Ot (A/Taiwan/64 [H2N2]), 
A/BEL/42 (A/Bdlamy/42 [H1N1]), A/MEM/71 (A/Memphis/I/71 
[H3N2]),  A/PR./8  (A/Puerto Rico/8/34  [H1N1]), and B/Lee 
(B/Lee/40) were grown in the allantoic cavity of 10-d-old embryo- 
hated hen's eggs and stored as infectious allantoic fluid as previ- 
ously described (27). Recombinant influenza strains A/JAP/BEL 
(A/Japan/305/57  x  A/Beilamy/42  [H2N1])  and  A/X-7F1 
(A/NWS/42 x A/1LI/5/57 [HON2]) were propagated in the same 
manner. Determination of virus titer, expressed  as hemagglutinating 
units  (HALT), was done as previously described (27). 
Cell Lines.  The A20-1.11 (H-2  J) B cell lymphoma (28) was 
maintained in 55% DMEM high glucose, (GIBCO BRL, Gaithers- 
burg, MD) and 35% DMEM low glucose, (GIBCO BILL) sup- 
plemented with 10%  (vol/vol) heat-inactivated fetal calf serum 
(HIFCS;  Hyclone  Laboratories,  Logan,  UT),  1%  glutamine 
(GIBCO  BRL),  1%  nonessential amino acids (GIBCO  BRL), 
5  x  10-s M 2-ME, and antibiotics (10 U/ml penicillin G and 
10/~g/ml streptomycin sulfate [GIBCO BILL]). The P815 (H-2  d) 
Ia- mastocytoma and MDCK cell line (10) were maintained in 
DMEM low glucose (GIBCO BRL), 10% HIFCS, 1% ghtamine, 
and antibiotics. 
Immunization of Mice for the Generation of Th2 and ThO Clones. 
Details of the immunization protocol have  been described  dsewhere 
(29). Briefly, 6-8-wk-old female BALB/c mice were immunized 
in the hind foot pads with a 1:1 suspension of UV-inactivated 
influenza A/JAP/57 (50 HAU) in phosphate-buffered saline (PBS, 
pH 7.3) and incomplete Freund's adjuvant (Difeo Laboratories, 
Detroit, MI). After 10-14 d, the animals were killed, and draining 
inguinal and popliteal lymph nodes were removed and processed 
through a tissue sieve  (Bellco  Ghss Inc., Vineland, NJ). For in vitro 
secondary bulk cultures, processed lymph node cells were washed 
once in serum-free  medium, treated with 1,000 HAU UV-mactivated 
virus, and plated in 6-well plates at a density of 25  x  106 cells 
per well in IMDM (GIBCO BILL), 10% HIFCS, 1% glutamine, 
5  x  10 -s M 2-ME, and antibiotics (complete media). 
Cloned T Lymphocyte Lines.  The procedures developed to es- 
tablish and maintain cytolytic influenza specific  bulk cultures and 
clones from spleens of  immunized mice are described in detail rise- 
where (30, 31). The procedure to isohte clones from lymph node 
bulks is as previously described (29). Briefly, cloues were derived 
by limiting dilution in 96-well flat-bottomed phtes from day 7 in 
vitro secondary bulk cultures. Specifically,  0.5, 1, or 5 bulk culture 
cells were plated per well with 106 irradiated (2,000 rad), vitally 
infected (1,000 HALT), syngeneic splenocytes in complete media, 
plus 10 U/nil human recombinant IL-2 (huRIb2) (Biosource In- 
ternational, Inc., Camarillo, CA) as a source of growth factor. The 
clones derived using this method were restimuhted every 10-14 d 
with irradiated, vitally infected, syngeueic splenocytes  in complete 
media plus 10 U/ml huRII.-2 and expanded to 6-well phtes (No. 
3506; Costar  Corp.,  Cambridge, MA) containing  lOVml clone 
cells, 4  x  106/ml infected, irradiated, syngeneic spleen cells, and 
10 U/nil huRIb2 in complete media. 
Cytokine Production.  Supernatants from clones were harvested 
48 h after stimulation in the absence of hulLlb2, and frozen at 
-20~  Production of IFN-7 was assayed  by ELISA as previously 
described with reagents provided by K. Schreiber (Washington 
University, St. Louis, MO) (32). Production of R,4, IL-5, and II,10 
was determined using a previously  descn~gl mouse cytokine ELISA 
protocol 0 3, Sehy,  D. W. [PharMingen], personal  communication). 
Briefly, the appropriate primasy mAb (anti-mouse I1,4, Ib5, or 
IL,10; PharMingen, San Diego, CA) was diluted to 0.5-4/lg/ml 
in 0.1 M NaHCO3  (pH 8.2) coating buffer, 50/~1 was added to 
wells of an enhanced protein binding ELISA plate (Cat. no. 25805- 
96, Coming Ghss Inc., Coming, NY), and the plates were sealed 
and incubated overnight at 4~  The phtes were then washed with 
PBS  +  0.05%  Tween 20 (Sigma Chemical Co., St. Louis, MO) 
twice and blocked with PBS +  10% FCS for 2 h at room tempera- 
ture. After washing the plate with PBS/Tween twice, standards 
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200 p.1/well  and incubated  overnight  at 4~  The phtes were washed 
four times with PBS/Tween, and then 100 #1 of the appropriate 
diluted biotinyhted anticytokine detecting mAb was added (0.5-4 
#g/ml in PBS +  10% FCS) and allowed to incubate at room tem- 
perature for 45 rain.  The plates were washed six  times with 
PBS/Tween and 100 #1 avidin-peroxidase (Sigma Chemical Co.) 
diluted 1:400 in PBS +  10% FCS was added and allowed to incu- 
bate at room temperature for 30 min, after which the plates were 
washed eight times with PBS/Tween. Within 5 min of use, ABTS 
substrate (150 mg 2,2'-Azino-bis(3-cthylbenzthiazoline-6-sulfonic 
acid) [from Sigma Chemical Co.] in 500 ml 0.1 M citric add in 
ddFIzO, pH 4.35) was mixed with 10/~1 H202 per 10 ml of sub- 
strate and plated 100 #l/well and allowed to develop at room tem- 
perature. ELISA plates were read at OD 405 um using an auto- 
mated microplate reader (model EL 340; Bio Tek Instruments, Inc., 
Winooski, VT). Quantities of each cytokine (IFN~, IL.4, ID5, 
and Ibl0) were extrapolated from standard curves generated for 
each ELISA assay. 
Lung Virus Titration by MDCK Cell  Plaque Assay.  TheMDCK 
cell plaque assay  for titration ofhng viral titers has been described 
in detail dsewhere (10). The following modifications to that pro- 
tocd were made. After the lungs were homogenized and prepared 
according to protocol,  serial dilutions from 10 -1 to 10 -s were 
m~de in cold PBS supplemented  with 0.75% BSA, 0.1 g/l MgCh, 
0.1 g/1 CaCh, and antibiotics. 50 #1 of each dilution was added 
to the MDCK monolayer in duplicate and incubated at room tem- 
perature for 30 min. The remainder of the procedure is as previ- 
ously described. Results are expressed as the mean plaque-forming 
units  determined by the calculation [(Number  of plaques per 
weLl)/0.05 roll  x  1/dilution factor. 
Assays  for Cell-mediated Cytotoxicity.  The SlCr release cytotox- 
icity assay  was carried out as previously  described (27). Briefly, 106 
target cells, either A20-1.11 or P815, were either left uninfected, 
infected with influenza A/JAP/57 or B/Lee in the presence of SlCr 
for 1.5 h at 37~  Targets  were then washed three times and plated 
5  x  103 cells/well in 96-well, fiat-bottomed, microtiter tissue cul- 
ture plates in 0.1 ml vol of RPMI +  10% HIFCS. Effector cells 
were added in a 0.1 ral vol of RPMI +  10% HIFCS to appropriate 
in quadruplicam E/T ratios ranged from 1:1 to 50:1 depending 
on assay. The plates were incubated at 37~  in 10% CO2 for 6 h. 
From each well, 0.1 ml of superuatant was removed and counted 
on an Isomedic Gamma Counter (ICN Biomedicals, Inc., Costa 
Mesa, CA). The percent specific  lysis  was determined as previously 
described (10). SEM were always  <5% of the mean value and are 
omitted. 
Assay of  CelhlarPro//feration.  The prolifia~tive  response of  cloned 
T cen lines was assessed by [3H]TdR  incorporation, as previously 
described (34). Results are expressed as the mean cpm of quadru- 
plicate cultures at the peak of the proliferative response (day  3 of 
culture). SEM were always  <10% of  the mean value  and are omitted. 
Intranasai Influenza Virus Inoculation.  Intranasal inoculation of 
mice was performed as previously described (10). The procedure 
was modified from that described by using light anesthesia from 
methox3dturane  (Pitman-Moore,  Mundelein, IL). To evaluate  a dose 
response to intranasal virus, animals received serial 10-fold dilu- 
tions of allantoic fluid in cold PBS ranging from 10 -2 to 10 -~ and 
animals were watched daily for morbidity and/or mortality. LDs0 
values were calculated  according  to a modified  Spearman and Karber 
method (35). 
Adopti~ Transfer  Procedure,  Adoptive  transfer of day 7 viable 
cloned cells was performed as previously described (10). 8-wk-old 
male BALB/c mice were intranasally inoculated with 10 LDs0 
influenza A/JAP/57 virus and within 30 min,  107 done cells in 
0.5 ml IMDM (GIBCO BRL) were injected intravenously. Con- 
trol mice were injected with 0.5 ml IMDM i.v. alone. Mice were 
watched daily for 21 d for morbidity and/or mortality. For deter- 
mination of lung viral titers and histology, mice were killed on 
day 4 or 5 post adoptive transfer. The lungs were then aseptically 
removed at the bronchi, snap-frozen  in liquid nitrogen, and frozen 
at  -70~  until used. 
Histolagic  Examination of  Lungs.  Frozen  lungs harvested  and de- 
scribed above were thawed in 10% buffered formalin and sent to 
American HistoLabs, Inc. (Gaithersburg, MD) where they were 
paraffin embedded and sectioned. Each lung specimen was stained 
with hemotoxylin and eosin or an ensinophil-specific stain, spe- 
cifically Lennert Giemsa or Luna. Morphometry was performed 
to quantitate the number of eosinophils present. Sections of right 
lung from each group were examined under high power oil im- 
mersion (100x) with a total of 400 high powered fields (HPF) 
counted per mouse recipient. 
Results 
Generation and  Characterization of CD4 +  Th2  Clones. 
BALB/c mice were inoculated in the hind footpad with nonin- 
fectious A/JAPAN/57 virus in incomplete Freund's adjuvant 
as described (Materials and Methods). Dr~inlng lymph nodes 
from four mice were harvested and individual lymph node 
ceU suspensions prepared. The lymph node calls were stimu- 
lated in vitro with noninfectious influenza virus. After 10 d, 
viable lymphoid cells were cloned under limiting dilutions 
conditions in the presence of A/JAPAN/57-infected,  irradi- 
ated splenocyte stimulators in medium supplemented with 
10 U/ml huILIL-2. From this cloning, thirteen stable T lym- 
phocyte clones were isolated and characterized. All dones were 
CD4 + and represented a heterogeneous array of CD4 + T 
lymphocyte subsets  including Thl, Th2,  and Th0 pheno- 
type clones (17, 36). Clones were maintained in continuous 
culture as described (Material and Methods). 
From this panel, two CD4 + clones, 5]34 and T5C8, were 
expanded for further characterization. These two clones dis- 
played the pattern of antigen dependent lymphokine produc- 
tion characteristic of CD4 §  Th2  T  cells.  Both  5B4  and 
T5C8 secreted IL-4, IL-5, and IL-10, but no detectable IFN-'y 
in response to influenza virus (Table 1). Another CD4 + T 
cell done, G1, showed a typical Thl pattern with secretion 
of IFN-3' in response to A/JAPAN/57  virus as previously 
reported (12). Neither 5B4 or T5C8 produced detectable IL-2 
as described in a bioassay using a CTLL variant which is sen- 
sitive to both IL-2 and IL-4 (not shown). 
Both done 5B4 and T5C8 were MHC restricted in their 
proliferative response  to  the  A/JAPAN/57  virus-treated 
splenocyte stimtdators (Fig. I a) as has been pmdously reported 
for the Thl clone G1  (12). These two Th2 clones did not 
proliferate in response to the antigenically unrelated type B 
influenza strain B/LEE (Fig. 1 a). To determine the target 
influenza polypeptides recognized by these Th2 clones,  the 
proliferative response of these clones to type A influenza virus 
field strains and reassortant viruses was evaluated.  The Th2 
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G1  5tM  T5C8 
Cytokine produced  (Thl)  (Th2)  (Th2) 
IFN~ (U/ml)*  254  <1  <1 
IL-4 (pg/ml)  <1  390  450 
IL-5 (pg/ml)  <1  1,367  1,789 
IL-10 (pg/ml)  <1  66  34 
* 48-h  culture  suprmamats  from  clones  stimulated with  irradiated, 
A/JAPAN/57-infected BALB/c splenocytes  in the absence of hulLIL-2 
were assayed on at least two separate occasions for cytokine production 
by ELISA (Materials and Methods). 
done T5C8 and the Thl clone G1 recognized virus strains 
expressing either the A/JAPAN/305/57 HA or strains  of 
the H2N2 subtype possessing structurally related HA pro- 
tein. This suggests that the Thl done G1 and the Th2 done 
T5C8 recognize sites on the A/JAPAN/57 HA (Fig.  1 b). 
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MHC restriction and fine antigen specificity of Thl and Th2 
clones. (a) 106 irradiated BALB/c (H-2d), C57B1/6 (H-2b), and C3H (H- 
2  k) splenocytes were mock infected or infected with influenza A/JAPAN/57 
or BLEE and cocultured with 2.5  x  104 clone cells for 72 h. Prolifera- 
tion of clones G1 (hatched bar), 5B4 (solid bar), and T5C8 (open bar) as 
measured by [3H]TdR. incorporation from quadruplicate cultures is shown. 
Data is representative of four independent assays. (b) Clones G1 (hatched 
bar), 5B4 (solid bar), and T5C8 (open bar) were cocultivated with BALB/c 
(H-2  a) splenocytes infected with different strains of influenza A virus (see 
Materials and Methods). Proliferation as measured by pH]TdK incorpo- 
ration from quadruplicate cultures is shown. Data is representative of three 
independent assays. 
In contrast, clone 51M recognizes only virus strains possessing 
the N2 neuraminidase, suggesting that this done recognizes 
a conserved site on the A/JAPAN/57 neuraminidase (Pig. I b). 
Both Th2  clones were  tested for cytolytic activity on 
A/JAPAN/57-infected A20-1.11 lymphoma calls that express 
I-A  a and I-E  d molecules. Neither done lysed infected A20- 
1.11 cells, but as previously reported by us (12), the G1 clone 
did show specific cytolytic activity on A/JAPAN/57 infected, 
but not uninfected A20-1.11 ceils (Fig.  2). To further test 
the cytolytic potential of TSC8 and 5B4, the two Th2 clones 
along with G1 were examined for lectin dependent cytolytic 
activity (37) by coincubation of cloned T ceils with target 
ceils in the presence of concanavalin A (5/~g/ml final in the 
assay) or phytohemagglutinin-p  (50 ~g/ml final in the assay). 
Only the cytolytic CD4 + clone G1 showed lectin-dependent 
cytolytic activity on uninfected target cells (data not shown). 
In  Vivo Antiviral Effector Activity of CD4 + Th2 Clones. 
To evaluate the antiviral activity of cloned Th2 T  ceils in 
vivo, clones 5IM and T5C8 and the Thl clone G1 were adop- 
tively ~  into lethally infected ~c  BALB/c mice. 
As  reported  previously  (12), the  CD4 +  Thl  done  G1 
promoted recovery from lethal A/JAPAN/57 virus infection 
(Fig. 3). In contrast, neither 51M nor T5C8 were able to pro- 
mote recovery from lethal infection after adoptive transfer 
(Hg. 3). This failure of the Th2 clones to promote recovery 
was repeatedly observed in four separate experiments carried 
out over 1 yr with cloned CD4 + T  cell populations main- 
rained in continuous in vitro culture over that period. 
In Vitr E~ector Activity and Pulmonary Virus Titers.  The 
recovery from lethal pulmonary influenza infection mediated 
by adoptively transferred CD8 + and CD4 + Thl T  ceils is 
associated with reduction in pulmonary virus titers (10, 12). 
To assess the effect of the Th2 clones on virus clearance, lethally 
infected recipients of clones 5B4, T5C8, and the Thl done 
G1 were killed at days 4 and 5 post infection and T cell transfer, 
80- 
6O 
-20 
1:1  5:1  10:1 
Effectm':.Target  Ratio 
Figure 2.  Cytolytic potential of Thl and Th2 clones. Clones G1 (I), 
5B4 (A), and T5C8 (e) were tested for reactivity on uninfected (open 
sTmba/~  ) or A/JAPAN/57-infected (solid symbols ) A20-1.11 target cells as 
described (Materials and Methods). Spontaneous release from uninfected 
and infected target cells was <10%. Data is representative of at least three 
separate experiments. 
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Figure 3.  Adoptive  transfer of Thl and Th2 clones into lethally chal- 
lenged BALB/c  mice. Within 30 rain of intranasal inoculation of a lethal 
dose of influenza A/JAPAN/57 into BALB/c mice, 107 done cells (day 
7 post stimuhtion) were injected intravenously. Mice were observed  for 
21 d for morbidity and mortality. Clones G1 (O), 5B4 (A), and T5C8 
(￿9  were injected into groups of five animals each. Five control animals 
(El) received no done. Results are representative of four experiments. 
and pulmonary virus titers determined.  As Table 2 shows, 
lung virus titers were decreased over 100-fold relative to con- 
trois in recipients of the CD4 + Thl clone G1.  In contrast, 
the recipients of the Th2 clones 5B4 and T5C8 showed no 
decrease in pulmonary virus titers compared with control in- 
fected animals which received no cells. It is noteworthy that 
for recipients of either Th2 done, lung virus titers were devated 
relative to controls. This slight enhancement  in virus levels 
at day 4 post infection  and transfer was observed for each 
Th2  done in two independent  experiments. 
In Vivo  Mo~holagic Correlates of Th2 T Cell Aaivity.  Lungs 
of control infected mice and recipients of the CD4 + T  cell 
clones were subjected to gross and microscopic pathologic 
Table  2.  Pulmonary Virus Titers in Recipients of Thl  or 
Th2 Clones 
Experiment  1"  Experiment  2 
Clone*  day 4  day 4  day 5 
G1 (Thl)  2.0  x  102*  5.1  x  103  NDS 
5B4 (Th2)  3.9  x  103  4.0  x  10  s  1.9  x  10  s 
T5C8 (Th2)  4.2  x  10  s  4.0  x  10  s  3.0  x  10  s 
No clone  7.3  x  104  7.3  x  104  2.1  x  104 
* 10~ cloned T cells were injected intravenously into BALB/c mice in- 
fected with 10 LDs0 of A/JAPAN/57 virus. Control mice were inject- 
ed with 0.5 ml of serum-free media. On the indicated day, mice were 
killed and lung homogenates prepared for virus titration. 
* Values are the plaque forming units of virus/ml of lung extract from 
individual mice at the indicated day post infection. Data are representa- 
tive of results in four separate experiments. 
S Not done. 
analysis. Grossly, at day 4 post infection, the lung of control 
infected mice and infected G1 recipients were well aerated 
with focal areas of hemorrhage and collapse. In contrast, the 
lungs of the Th2 done recipients showed extensive conges- 
tion  and diffuse collapse (not  shown). 
The most striking difference in the response pattern of the 
Th2 done recipients was evident at the microscopic level (Fig. 
4). At day 4 post infection, lungs of control mice had histo- 
logic changes typical of early influenza pneumonitis  with 
patchy involvement of medium and small airways, focal necrosis 
of respiratory epithdium,  and peribronchiolar  and intraal- 
veolar  infiltrate  consisting  of mononuclear  and  polymor- 
phonudear  leukocytes  (Fig.  4  a).  Recipients  of done  G1 
showed few loci of inflammation  with modest evidence of 
perivascular accumulation of lymphoblasts in focal areas of 
pneumonia (Fig. 4 b). In contrast, the lungs of SB4 and T5C8 
recipients were more diffusely involved with a dense accumu- 
lation of polymorphonudear lenkocytes around vessels and 
airway walls (Fig. 4 c) which was not evident in sections from 
control or G1 recipients. 
When sections of hngs from infected control and done 
recipients were stained with the Lennart's  Giemsa or Luna 
stain  to highlight  eosinophils,  extensive infiltration  of the 
lungs of Th2 recipients by eosinophils was evident (Fig.  4 
d). Fig. 5 shows quantitative morphometry data on the fre- 
quency and density of eosinophils in 400 microscopic fields 
taken from sections of control and done recipients.  More than 
20% of fields from the lungs of Th2 recipients showed two 
or greater eosinophils per HPF. Sections from control or G1 
recipients had <1% of rid& showing significant eosinophil 
accumulation. 
Discussion 
In this report we demonstrate that clonal populations of 
CD4 +  T  lymphocytes  with  different  cytoldne  secretion 
profiles have distinctly different in vivo effector activities in 
response to pulmonary influenza inftction. Specifically,  two 
CD4 + dunes with a Th2 cytokine profile failed to promote 
recovery from lethal type A  influenza infection after adop- 
tive tramfer, whereas a CD4 + Thl done promoted recovery. 
Recipients of these two Th2 clones, however, did show a 
marked eosinophil infiltration in sections of their lungs. Also, 
whereas the Thl  done G1 reduced pulmonary virus titcrs 
in infected recipients,  the recipients of the two Th2 clones 
had slightly elevated pulmonary virus titers relative to con- 
trol infected animals that received no T cells. These findings 
raise the possibility that in this model of experimental pul- 
monary virus infection, induction of a CD4 + Th2 response 
may lead not to recovery from infection, but rather  to an 
immunopotentiation  of viral infection and injury. 
The role of CD4 + T  lymphocytes in virus elimination 
and recovery from experimental virus infection is not com- 
pletely understood (3). In the murine influenza model, early 
evidence suggested that induction of a CD4 + T cell response 
during pulmonary infection leads to an increase in pulmo- 
nary inflammation and enhanced morbidity 08). At least one 
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Filp~ S.  Quantitative morphometry 
on hng sectiom  fzom  mice  ado~vdy  tram- 
ferred with Thl or Th2 clones. 8-wk-old 
BALB/c mice were intnnasally infected 
with a 10 LDs0  dose  of A/JAPAN/57 and 
injected with  107 clone cells or media 
done within  30 rain as described  (Materials 
and Methods). Mice  were killed  and their 
hngs weze  asepti~ removed  on day  4 and 
subsequently  se~t  for histologic  sectiom  and 
Staining with the eosinophil  specific  Len- 
nert Giemsa  stain.  Sectiom  weze  r 
by a blinded observer and 400 individual 
lOOx  FIPF  were  evaluated  per groulx  Data 
from  each  is group  is shown  separately,  (a) 
No Clone, (b) (31, (c) SB4, and (d) T5C_,8. 
The m~her of e~N/nophih  counted  pe~ I-WF 
is indicated  on the x-axis and the number 
of HPF with that number of eodnophih 
is indicated  on the y-axis.  Data  is represen- 
tative of two separate experiments. 
subsequent report is in agreement with this view (13). On 
the other hand, studies with donal populations of activated 
inthenza-specific CIM + T lymphocytes suggest that CD4 + 
T  cells can upon adoptive transfer into infected recipients, 
promote virus dimlnation from the lungs and recovery (12, 
39). The findings reported here and our earlier studies (12) 
on the in vivo effector activity of the CD4 + Thl done G1 
are consistent with this view. Also, virus elimination and 
recovery from experimental pulmonary influenza infection 
has been reported in mice lacking functional CD8 + T lym- 
phocytes (14).  This htter finding suggests that CD4 + T 
lymphocytes can orchestrate recovery from influenza infec- 
tion in the absence of CD8 + T  lymphocytes although the 
m~firement for CD8 + T cells in recovery may be dependent 
on the virulence of the challenge virus (40). 
The mechanism(s) by which CD4 + Thl T  cells like the 
G1 done promote virus clearance and recovery from pulmo- 
nary virus infection are not well understood. Scherle et al. 
0 9) have shown that adoptively transferred CIM + T  cells 
can provide help for the production of neutralizing antiin- 
fluenza virus antibody. This antibody response in turn l__~_s 
to virus dearance from the lungs of infected T cell-defident 
(nude)  mice-  Furthermore, these investigators have shown 
that transfer of nentt~lizing anti-HA antibody alone into in- 
fected SCID mice leads to influenza virus clearance from the 
lungs of these immunoddicient mice (41). To date, we have 
been unable to demonstrate enhanced antibody production 
after transfer of either the Thl done (31 or the Th2 clones, 
5134 or T5C8  into A/JAPAN/57-immunized nude nnce 
(Graham, M. R, and T.J. Bradale, unpublished observations). 
The reasons for this are not dear. Differences in the B cell 
response to diffegent influenza virus strains is one possible 
explanation for the apparent lack orb cell help observed with 
these clones. In the studies of Scherle et al. (39, 41) influenza 
viruses of the HIN1 and FI3N2 subtype were used, whereas 
the A/JAPAN/57 virus used in our transfer study is of the 
H2N2 subtype. Influenza viruses of the H2N2 subtype have 
been reported to be mitogenic for B cells of the H-2  a haplo- 
type (42).  Whether virus strain differences can account for 
the lack of CD4 + T  cell  help and/or alteration in B  cell 
function under our ~ental  conditions awaits to be de- 
termined. 
In addition to help for antibody responses,  CD4 + T cells 
could promote recovery from infection by direct cytolysis of 
MHC class II positive virus-infected cells and/or by antigen 
dependent rdease of cytokines with antiviral activity. Recent 
evidence in the influenza model (43) suggests that an impor- 
tant inflammatory cytokine produced by CD4 + Thl T ceils, 
Figure 4.  Moptive transf~ of  Th2 clones  leads to massive  pulmonary  eosinophilia_  4 d post intranasal  challenge  with a lethal  dose  of A/JAPAN~57 
and adoptive  m,d*r of 107 T cell  dunes. ~  wese  killed  and the3Lr  lungs  were  nano~l, map frozen, and stored  at -700C until examination  (Materials 
and Methods). Iang u~-tiom  were s-i-d with the eosinophil  qmific Lennm's Gimm stain. Repmentative  10x magnif~tion (original) m  shown 
in a, b, and c: (a) Control ~  recipient, (b) Recipient  of Thl done G1. (c) Redpient of Th2 done 5134. D shows a high power (100x) original 
mag-ifmttion  of an area with eztensive infiltratiun  in recipient of Th2 done 5B4. 
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CD4 + T  cells in vivo in experimental influenza infection. 
The contribution of other T cell cytokines and contact de- 
pendent cytolytic activity is currently being mined. 
The failure of the Th2 T cell dunes to promote virus dear- 
ance and recovery was unexpected in view of the evidence 
that Th2 T cells augment antibody responses (18, 44). That 
the two Th2 dones were functional in vivo was evidenced 
by the cosinophilrich inflammatory  response that they evoked 
in the recipient mice. Perhaps more surprising was the finding 
that Th2 recipients had slightly higher pulmonary virus titers 
than controls. This raises the possibility that the induction 
of a strong Th2 response during viral infection could sup- 
press other host defense mechanisms. In view of the inhibi- 
tory role of the Th2 cytokine IL-10 on CD4 + Thl T  cell 
induction, (45), IL-10-mediated suppression of a CD4 + Thl 
response could be one mechanism to account for devated virus 
titers in the recipients of Th2 clones. 
Our findings on the in vivo effect of virus-specific Th2 
T cells are similar in some respects to recent results of Alwan 
et al. (26). In an experimental murine model of respiratory 
syncytial virus (RSV) infection, these investigators showed 
an cosinophil-rich exudate in bronchial lavage from gSV- 
infected recipients of RSV-specific  CD4 + T  ceils enriched 
for the Th2 like cytokine activity.  In that model, Th2 cells 
both enhanced morbidity and inflammation and enhanced 
viral clearance after adoptive transfer (26). Since RSV infec- 
tion in mice is mild and self limited (46), it is possible that 
the antiviral effect as well as the immunopathologic effect 
of transferred Th2 T cells may reflect the same T cell effector 
mechanisms operating in an otherwise self limiting disease. 
It is also noteworthy that in the MAIDS murine model of 
immunodeficiency  virus infection, the production of the Th2 
cytokine IL-4 may play a central role in disease pathogenesis 
and progression (24). Additionally, induction of a Th2 T cell 
response has also been proposed to play an important role 
in the pathogenesis of human HIV infection (25). 
In the current report we have used activated donal popu- 
lations of virus-specific CD4 § Th2 T cells to address the in 
vivo role this T cell subset may play in recovery from over- 
whdming viral infection. In our hands Th2 T cells represent 
the minority of the CD4 + T cell response definable in vitro 
at the donal level (Grah~ra, M. B., unpublished obsm'vatiom). 
Recent observations by Carding et al. (47) suggest a more 
complicated pattern of T cell responses to virus infection in 
vivo. These investigators reported that during experimental 
pulmonary influenza infection, both Thl and Th2 cytokines 
are activated in the lung as determined by cytokine gene tran- 
scription. It is likely that the CD4 + T cell response during 
viral infiction reflects a balance between antiviral effector mech- 
anisms and inhibitory or regulatory mechanisms with no di- 
rect antiviral activity. 
In conclusion our data suggest that during acute infection 
with a lyric virus, such as type A influenza, CD4 + T cells 
of the Th2 subset may not play a primary role in virus dear- 
ance and recovery. Furthermore, these data raise the possi- 
bility that the induction of a CD4 + T cell response against 
a lytic virus like influenza could lead to immune-mediated 
potentiation of injury. It will be important to determine the 
extent to which CD4 + Th2 T cells contribute to immune 
mediated pathology during viral infection and the mecha- 
nisms by which Th2 T  cells produce injury. 
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